 Document Security Systems Incs NYSE: DSS subsidiary, DSS Biomedical International, Inc., has completed a 1 million equity investment in Vivacitas Oncology, Inc. Vivacitas Oncology focuses on developing new treatment options to treat cancers resistant to currently available therapies. 